HEADER PHOTOSYNTHESIS 23-SEP-22 8EL5 TITLE LIGHT HARVESTING PHYCOBILIPROTEIN HAPE555 FROM THE CRYPTOPHYTE TITLE 2 HEMISELMIS ANDERSENII CCMP644 IN AN ALTERNATING TIGHT TO LOOSE TITLE 3 INTERFACE FILAMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHYCOERYTHRIN ALPHA-1 SUBUNIT; COMPND 3 CHAIN: A, G, J, K; COMPND 4 SYNONYM: PHYCOERYTHRIN PE555 ALPHA-1 SUBUNIT,PE555A-1; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PHYCOERYTHRIN550 BETA SUBUNIT; COMPND 7 CHAIN: B, D, F, H; COMPND 8 MOL_ID: 3; COMPND 9 MOLECULE: PHYCOERYTHRIN ALPHA-2 SUBUNIT; COMPND 10 CHAIN: C, E, I, L; COMPND 11 SYNONYM: PHYCOERYTHRIN PE555 ALPHA-2 SUBUNIT,PE555A-2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 3 ORGANISM_TAXID: 464988; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 6 ORGANISM_TAXID: 464988; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 9 ORGANISM_TAXID: 464988 KEYWDS PHYCOBILIPROTEIN, ANTENNA, LIGHT HARVESTING, CRYPTOPHYTE, ALGAE, KEYWDS 2 GLOBIN, CALM, CARSP, PHOTOSYNTHESIS, PHYCOERYTHRIN, HEMISELMIS EXPDTA X-RAY DIFFRACTION AUTHOR H.W.RATHBONE,K.A.MICHIE,A.L.LAOS,P.M.G.CURMI REVDAT 3 29-NOV-23 8EL5 1 JRNL REVDAT 2 15-NOV-23 8EL5 1 JRNL REVDAT 1 25-OCT-23 8EL5 0 JRNL AUTH H.W.RATHBONE,A.J.LAOS,K.A.MICHIE,H.IRANMANESH,J.BIAZIK, JRNL AUTH 2 S.C.GOODCHILD,P.THORDARSON,B.R.GREEN,P.M.G.CURMI JRNL TITL MOLECULAR DISSECTION OF THE SOLUBLE PHOTOSYNTHETIC ANTENNA JRNL TITL 2 FROM THE CRYPTOPHYTE ALGA HEMISELMIS ANDERSENII. JRNL REF COMMUN BIOL V. 6 1158 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 37957226 JRNL DOI 10.1038/S42003-023-05508-4 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 104107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.920 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.6600 - 4.0300 0.99 7431 147 0.1587 0.1705 REMARK 3 2 4.0200 - 3.1900 1.00 7375 143 0.1583 0.2188 REMARK 3 3 3.1900 - 2.7900 1.00 7331 142 0.1745 0.2511 REMARK 3 4 2.7900 - 2.5400 1.00 7342 145 0.1787 0.2349 REMARK 3 5 2.5400 - 2.3500 1.00 7299 141 0.1798 0.2239 REMARK 3 6 2.3500 - 2.2200 1.00 7289 143 0.1829 0.2229 REMARK 3 7 2.2100 - 2.1000 1.00 7297 140 0.1854 0.2333 REMARK 3 8 2.1000 - 2.0100 1.00 7295 145 0.2016 0.2919 REMARK 3 9 2.0100 - 1.9300 1.00 7264 135 0.2378 0.3034 REMARK 3 10 1.9300 - 1.8700 1.00 7284 144 0.2484 0.2951 REMARK 3 11 1.8700 - 1.8100 1.00 7230 143 0.2729 0.3367 REMARK 3 12 1.8100 - 1.7600 1.00 7269 139 0.3122 0.3472 REMARK 3 13 1.7600 - 1.7100 0.99 7226 151 0.3529 0.3653 REMARK 3 14 1.7100 - 1.6700 0.98 7177 140 0.4090 0.4899 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.291 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.613 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 10003 REMARK 3 ANGLE : 1.446 13578 REMARK 3 CHIRALITY : 0.063 1456 REMARK 3 PLANARITY : 0.009 1722 REMARK 3 DIHEDRAL : 17.105 3640 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8EL5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1000268708. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 104433 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670 REMARK 200 RESOLUTION RANGE LOW (A) : 61.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.14 REMARK 200 STARTING MODEL: 4LMX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 30.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350 (W/V) + 2% (W/V) REMARK 280 BENZAMIDINE HCL, 150 NL MOTHER + 150 NL PROTEIN SOLUTION, REMARK 280 CRYOPROTECTANT OF 20% GYLCEROL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.79800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 65 REMARK 465 SER A 66 REMARK 465 VAL A 67 REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 ASP B 3 REMARK 465 ALA B 4 REMARK 465 MET D 1 REMARK 465 LEU D 2 REMARK 465 ASP D 3 REMARK 465 MET F 1 REMARK 465 LEU F 2 REMARK 465 ASP F 3 REMARK 465 ALA F 4 REMARK 465 LYS G 65 REMARK 465 SER G 66 REMARK 465 VAL G 67 REMARK 465 MET H 1 REMARK 465 LEU H 2 REMARK 465 ASP H 3 REMARK 465 ALA H 4 REMARK 465 LYS J 65 REMARK 465 SER J 66 REMARK 465 VAL J 67 REMARK 465 LYS K 65 REMARK 465 SER K 66 REMARK 465 VAL K 67 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP D 101 OG SER D 103 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ALA B 12 HD22 ASN I 58 2546 1.46 REMARK 500 O ALA B 12 ND2 ASN I 58 2546 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 13 -38.46 -38.62 REMARK 500 THR B 75 150.54 81.73 REMARK 500 SER B 152 76.23 -100.24 REMARK 500 ASN D 70 -0.54 70.15 REMARK 500 THR D 75 148.82 73.86 REMARK 500 ASN F 70 -1.05 68.50 REMARK 500 THR F 75 153.22 77.25 REMARK 500 THR H 75 149.29 80.44 REMARK 500 ASN H 111 104.50 -59.42 REMARK 500 REMARK 500 REMARK: NULL DBREF 8EL5 A 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL5 B 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL5 C 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL5 D 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL5 E 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL5 F 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL5 G 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL5 H 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL5 I 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL5 J 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL5 K 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL5 L 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 SEQADV 8EL5 VAL B 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL5 VAL D 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL5 VAL F 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL5 VAL H 172 UNP U5T8W0 GLU 172 CONFLICT SEQRES 1 A 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 A 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 A 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 A 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 A 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 A 67 SER VAL SEQRES 1 B 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 B 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 B 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 B 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 B 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 B 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 B 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 B 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 B 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 B 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 B 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 B 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 B 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 B 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 C 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 C 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 C 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 C 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 C 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 D 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 D 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 D 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 D 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 D 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 D 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 D 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 D 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 D 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 D 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 D 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 D 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 D 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 D 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 E 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 E 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 E 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 E 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 E 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 F 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 F 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 F 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 F 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 F 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 F 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 F 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 F 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 F 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 F 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 F 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 F 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 F 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 F 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 G 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 G 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 G 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 G 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 G 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 G 67 SER VAL SEQRES 1 H 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 H 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 H 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 H 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 H 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 H 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 H 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 H 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 H 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 H 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 H 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 H 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 H 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 H 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 I 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 I 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 I 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 I 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 I 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 J 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 J 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 J 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 J 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 J 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 J 67 SER VAL SEQRES 1 K 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 K 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 K 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 K 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 K 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 K 67 SER VAL SEQRES 1 L 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 L 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 L 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 L 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 L 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU MODRES 8EL5 LYZ A 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ C 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ E 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ G 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ I 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ J 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ K 4 LYS MODIFIED RESIDUE MODRES 8EL5 LYZ L 4 LYS MODIFIED RESIDUE HET LYZ A 4 21 HET LYZ C 4 21 HET LYZ E 4 21 HET LYZ G 4 21 HET LYZ I 4 21 HET LYZ J 4 21 HET LYZ K 4 21 HET LYZ L 4 21 HET PEB A 101 80 HET AX9 B 201 79 HET PEB B 202 80 HET PEB B 203 80 HET PEB C 101 80 HET GOL C 102 13 HET AX9 D 201 79 HET PEB D 202 80 HET PEB D 203 80 HET PEB E 101 80 HET GOL E 102 13 HET AX9 F 201 79 HET PEB F 202 80 HET PEB F 203 80 HET PEB G 101 80 HET GOL G 102 14 HET AX9 H 201 79 HET PEB H 202 80 HET PEB H 203 80 HET PEB I 101 80 HET PEB J 101 80 HET GOL J 102 13 HET PEB K 101 80 HET GOL K 102 13 HET PEB L 101 80 HET GOL L 102 14 HETNAM LYZ 5-HYDROXYLYSINE HETNAM PEB PHYCOERYTHROBILIN HETNAM AX9 DICYS-(15,16)-DIHYDROBILIVERDIN HETNAM GOL GLYCEROL HETSYN AX9 15,16-DIHYDROBILIVERDIN (DOUBLE CYS BOUND FORM); 3- HETSYN 2 AX9 [(2Z)-2-({3-(2-CARBOXYETHYL)-5-[(Z)-(3-ETHYL-4-METHYL- HETSYN 3 AX9 5-OXO-1,5-DIHYDRO-2H-PYRROL-2-YLIDENE)METHYL]-4- HETSYN 4 AX9 METHYL-1H-PYRROL-2-YL}METHYLIDENE)-5-{[(2R)-4-ETHYL-3- HETSYN 5 AX9 METHYL-5-OXO-2,5-DIHYDRO-1H-PYRROL-2-YL]METHYL}-4- HETSYN 6 AX9 METHYL-2H-PYRROL-3-YL]PROPANOIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 LYZ 8(C6 H14 N2 O3) FORMUL 13 PEB 16(C33 H40 N4 O6) FORMUL 14 AX9 4(C33 H40 N4 O6) FORMUL 18 GOL 6(C3 H8 O3) FORMUL 39 HOH *339(H2 O) HELIX 1 AA1 ASN A 46 TYR A 57 1 12 HELIX 2 AA2 SER B 6 SER B 11 1 6 HELIX 3 AA3 GLY B 21 LYS B 28 1 8 HELIX 4 AA4 GLU B 33 ASN B 47 1 15 HELIX 5 AA5 ASN B 47 ASN B 63 1 17 HELIX 6 AA6 PRO B 64 ALA B 68 5 5 HELIX 7 AA7 THR B 75 GLY B 100 1 26 HELIX 8 AA8 SER B 102 CYS B 109 1 8 HELIX 9 AA9 GLY B 112 GLY B 121 1 10 HELIX 10 AB1 PRO B 123 THR B 143 1 21 HELIX 11 AB2 CYS B 158 ALA B 177 1 20 HELIX 12 AB3 ASN C 46 TYR C 57 1 12 HELIX 13 AB4 PHE D 5 SER D 11 1 7 HELIX 14 AB5 GLY D 21 VAL D 31 1 11 HELIX 15 AB6 GLU D 33 ASN D 47 1 15 HELIX 16 AB7 ASN D 47 ASN D 63 1 17 HELIX 17 AB8 PRO D 64 ALA D 68 5 5 HELIX 18 AB9 THR D 75 GLY D 100 1 26 HELIX 19 AC1 SER D 102 CYS D 109 1 8 HELIX 20 AC2 GLY D 112 GLY D 121 1 10 HELIX 21 AC3 PRO D 123 THR D 143 1 21 HELIX 22 AC4 CYS D 158 ALA D 177 1 20 HELIX 23 AC5 ASN E 46 TYR E 57 1 12 HELIX 24 AC6 SER F 6 SER F 11 1 6 HELIX 25 AC7 GLY F 21 VAL F 31 1 11 HELIX 26 AC8 GLU F 33 ASN F 47 1 15 HELIX 27 AC9 ASN F 47 ASN F 63 1 17 HELIX 28 AD1 PRO F 64 ALA F 68 5 5 HELIX 29 AD2 THR F 75 GLY F 100 1 26 HELIX 30 AD3 SER F 102 CYS F 109 1 8 HELIX 31 AD4 GLY F 112 GLY F 121 1 10 HELIX 32 AD5 PRO F 123 THR F 143 1 21 HELIX 33 AD6 CYS F 158 ALA F 177 1 20 HELIX 34 AD7 ASN G 46 TYR G 57 1 12 HELIX 35 AD8 SER H 6 SER H 11 1 6 HELIX 36 AD9 GLY H 21 VAL H 31 1 11 HELIX 37 AE1 GLU H 33 ASN H 47 1 15 HELIX 38 AE2 ASN H 47 ASN H 63 1 17 HELIX 39 AE3 PRO H 64 ALA H 68 5 5 HELIX 40 AE4 THR H 75 GLY H 100 1 26 HELIX 41 AE5 SER H 102 CYS H 109 1 8 HELIX 42 AE6 GLY H 112 GLY H 121 1 10 HELIX 43 AE7 PRO H 123 THR H 143 1 21 HELIX 44 AE8 CYS H 158 ALA H 177 1 20 HELIX 45 AE9 ASN I 46 TYR I 57 1 12 HELIX 46 AF1 ASN J 46 TYR J 57 1 12 HELIX 47 AF2 ASN K 46 TYR K 57 1 12 HELIX 48 AF3 ASN L 46 TYR L 57 1 12 SHEET 1 AA1 5 LYS A 7 ASP A 15 0 SHEET 2 AA1 5 PHE A 34 ALA A 42 -1 O SER A 39 N CYS A 10 SHEET 3 AA1 5 ALA B 17 GLY B 20 -1 O ALA B 17 N VAL A 38 SHEET 4 AA1 5 PHE I 34 ALA I 42 -1 N VAL I 38 O ALA B 17 SHEET 5 AA1 5 LYS I 7 ASP I 15 -1 N CYS I 10 O SER I 39 SHEET 1 AA2 5 LYS C 7 ASP C 15 0 SHEET 2 AA2 5 PHE C 34 ALA C 42 -1 O SER C 39 N CYS C 10 SHEET 3 AA2 5 ALA D 17 GLY D 20 -1 O ALA D 17 N VAL C 38 SHEET 4 AA2 5 PHE J 34 ALA J 42 -1 N VAL J 38 O ALA D 17 SHEET 5 AA2 5 LYS J 7 ASP J 15 -1 N CYS J 10 O SER J 39 SHEET 1 AA3 5 LYS E 7 ASP E 15 0 SHEET 2 AA3 5 PHE E 34 ALA E 42 -1 O SER E 39 N CYS E 10 SHEET 3 AA3 5 ALA F 17 GLY F 20 -1 O ALA F 17 N VAL E 38 SHEET 4 AA3 5 PHE K 34 ALA K 42 -1 N VAL K 38 O ALA F 17 SHEET 5 AA3 5 LYS K 7 ASP K 15 -1 N CYS K 10 O SER K 39 SHEET 1 AA4 5 LYS G 7 ASP G 15 0 SHEET 2 AA4 5 PHE G 34 ALA G 42 -1 O SER G 39 N CYS G 10 SHEET 3 AA4 5 ALA H 17 GLY H 20 -1 O ALA H 17 N VAL G 38 SHEET 4 AA4 5 PHE L 34 ALA L 42 -1 N VAL L 38 O ALA H 17 SHEET 5 AA4 5 LYS L 7 ASP L 15 -1 N CYS L 10 O SER L 39 LINK C ALYS A 3 N ALYZ A 4 1555 1555 1.32 LINK C ALYZ A 4 N AASP A 5 1555 1555 1.33 LINK SG ACYS A 20 CAAAPEB A 101 1555 1555 1.82 LINK SG CYS B 50 CBA AX9 B 201 1555 1555 1.88 LINK SG CYS B 61 CAD AX9 B 201 1555 1555 1.87 LINK SG CYS B 82 CAA PEB B 202 1555 1555 1.86 LINK SG CYS B 158 CAA PEB B 203 1555 1555 1.88 LINK C ALYS C 3 N ALYZ C 4 1555 1555 1.32 LINK C ALYZ C 4 N AASP C 5 1555 1555 1.33 LINK SG ACYS C 20 CAAAPEB C 101 1555 1555 1.82 LINK SG CYS D 50 CBA AX9 D 201 1555 1555 1.81 LINK SG CYS D 61 CAD AX9 D 201 1555 1555 1.88 LINK SG CYS D 82 CAA PEB D 202 1555 1555 1.90 LINK SG CYS D 158 CAA PEB D 203 1555 1555 1.91 LINK C ALYS E 3 N ALYZ E 4 1555 1555 1.33 LINK C ALYZ E 4 N AASP E 5 1555 1555 1.32 LINK SG ACYS E 20 CAAAPEB E 101 1555 1555 1.85 LINK SG CYS F 50 CBA AX9 F 201 1555 1555 1.85 LINK SG CYS F 61 CAD AX9 F 201 1555 1555 1.81 LINK SG CYS F 82 CAA PEB F 202 1555 1555 1.96 LINK SG CYS F 158 CAA PEB F 203 1555 1555 1.87 LINK C ALYS G 3 N ALYZ G 4 1555 1555 1.33 LINK C ALYZ G 4 N AASP G 5 1555 1555 1.32 LINK SG ACYS G 20 CAAAPEB G 101 1555 1555 1.77 LINK SG CYS H 50 CBA AX9 H 201 1555 1555 1.88 LINK SG CYS H 61 CAD AX9 H 201 1555 1555 1.90 LINK SG CYS H 82 CAA PEB H 202 1555 1555 1.87 LINK SG CYS H 158 CAA PEB H 203 1555 1555 1.87 LINK C BLYS I 3 N BLYZ I 4 1555 1555 1.32 LINK C BLYZ I 4 N BASP I 5 1555 1555 1.33 LINK SG BCYS I 20 CAABPEB I 101 1555 1555 1.82 LINK C BLYS J 3 N BLYZ J 4 1555 1555 1.32 LINK C BLYZ J 4 N BASP J 5 1555 1555 1.33 LINK SG BCYS J 20 CAABPEB J 101 1555 1555 1.82 LINK C BLYS K 3 N BLYZ K 4 1555 1555 1.33 LINK C BLYZ K 4 N BASP K 5 1555 1555 1.32 LINK SG BCYS K 20 CAABPEB K 101 1555 1555 1.85 LINK C BLYS L 3 N BLYZ L 4 1555 1555 1.33 LINK C BLYZ L 4 N BASP L 5 1555 1555 1.32 LINK SG BCYS L 20 CAABPEB L 101 1555 1555 1.77 CRYST1 64.856 75.596 99.360 90.00 110.30 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015419 0.000000 0.005705 0.00000 SCALE2 0.000000 0.013228 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010731 0.00000